mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.00043 |
1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.065 |
0.06 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.009 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.00036 |
1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
-0.028 |
0.4 |